Venus Medtech Hangzhou has been granted a patent for a method to test prosthetic heart valve leaflets. The method involves using a specialized apparatus with a vertical post, horizontal bar, linear actuator, light source, gauge, and detector to accurately measure and detect the leaflet’s properties. GlobalData’s report on Venus Medtech Hangzhou gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Venus Medtech Hangzhou, Prosthetic cardiac valves was a key innovation area identified from patents. Venus Medtech Hangzhou's grant share as of May 2024 was 37%. Grant share is based on the ratio of number of grants to total number of patents.
Method for testing prosthetic heart valve leaflet using apparatus
A recently granted patent (Publication Number: US11980547B2) discloses a method for testing prosthetic heart valve leaflets using a specialized apparatus. The method involves placing the leaflet across a horizontal bar supported by a vertical post and activating the apparatus to move the bar vertically, emit a beam of light, measure the elevation of the bar above the beam, and generate a detection signal indicative of the beam detection. The apparatus includes a linear actuator, a light source, a gauge, and a detector to facilitate the testing process efficiently.
Furthermore, the patent claims detail additional features such as the orientation of the bar extending laterally away from the post, the adjustability of the light source to direct the beam horizontally through the bar-plane, and the presence of a platform with a guide for positioning the leaflet accurately. The method also involves the use of a clamping element, such as a rod and a spring, to clamp the leaflet to the bar securely during testing. These features aim to provide a comprehensive and precise testing process for prosthetic heart valve leaflets, ensuring accurate results and reliable performance evaluation.
To know more about GlobalData’s detailed insights on Venus Medtech Hangzhou, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.